Constitution Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.7M Buy
8,941
+7,711
+627% +$7.88M 5.51% 3
2026
Q1
$1.13M Hold
1,230
0.57% 31
2025
Q4
$1.32M Sell
1,230
-300
-20% -$287K 0.63% 29
2025
Q3
$1.17M Buy
1,530
+200
+15% +$149K 0.55% 29
2025
Q2
$1.04M Hold
1,330
0.53% 32
2025
Q1
$1.1M Buy
1,330
+30
+2% +$25K 0.61% 30
2024
Q4
$1M Buy
1,300
+20
+2% +$16.6K 0.56% 27
2024
Q3
$1.13M Sell
1,280
-25
-2% -$22.5K 0.61% 23
2024
Q2
$1.18M Sell
1,305
-2,050
-61% -$1.64M 0.62% 26
2024
Q1
$2.61M Buy
3,355
+2,910
+654% +$2.07M 1.47% 15
2023
Q4
$259K Buy
+445
New +$260K 0.16% 53

Other funds holding LLY

Constitution Capital's LLY Position: Q2 2026 in Review

Constitution Capital increased its Eli Lilly (LLY) stake by 627% in Q2 2026, buying an estimated $7.88M and bringing the position to 8,941 shares worth $10.7M. The position accounts for 5.51% of the portfolio, ranked #3.

Constitution Capital first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. 1,766 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Constitution Capital held 8,941 shares of Eli Lilly worth $10.7M as of Q2 2026.
  • Constitution Capital bought 7,711 Eli Lilly shares in Q2 2026, an estimated $7.88M.
  • Eli Lilly made up 5.51% of Constitution Capital's portfolio in Q2 2026, its #3 holding.
  • Constitution Capital first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
  • 1,766 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Constitution Capital's 13F filing for Q2 2026, filed 9 Jul 2026.